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Resistance to toxic oxyanions of arsenic  and  anti- 
mony in Escherichia  coli is conferred by the conjuga- 
tive R-factor  R773,  which  encodes an  ATP-driven  an- 
ion extrusion pump. The ars operon is composed of 
three  structural genes, arsA,  arsB, and arsC. Although 
transcribed  as a single  unit,  the  three  genes  are  differ- 
entially  expressed as a result of translational  differ- 
ences,  such  that  the ArsA and ArsC proteins are pro- 
duced  in  high  amounts  relative  to  the  amount of ArsB 
protein made. Consequently, biochemical character- 
ization of the  ArsB  protein,  which  is  an  integral mem- 
brane protein  containing  the  anion-conducting  path- 
way,  has been limited,  precluding  studies of the mech- 
anism of this  oxyanion  pump.  To  overexpress  the arsB 
gene, a series of changes  were made. First,  the second 
codon, an  infrequently used leucine codon, was 
changed  to a more  frequently utilized codon. Second, a 
GC-rich stem-loop (AG = -17 kcal/mol) between the 
third  and  twelfth codons was destabilized  by changing 
several of the  bases of the  base-paired region. Third, 
the re-engineered arsB gene  was fused 3’ in  frame  to 
the  first  1458 base pairs of the arsA gene  to  encode a 
914-residue  chimeric  protein  (486  residues of the ArsA 
protein plus 428 residues of the mutated  ArsB  protein) 
containing  the  entire  re-engineered  ArsB  sequence  ex- 
cept  for  the  initiating methionine. The ArsA-ArsB  chi- 
mera  has been overexpressed at  -15-20% of the  total 
membrane  proteins.  Cells  producing  the  chimeric 
ArsA-ArsB protein with an arsA gene in trans ex- 
cluded 73AsO; from  cells, demonstrating  that  the chi- 
mera can function as a component of the oxyanion- 
translocating ATPase. 
The  arsenical resistance (ars) operon of the conjugative R- 
factor R733 of Escherichia coli provides resistance to oxy- 
anions of arsenic  and  antimony (1). Resistance derives  from 
the action of an  operon-encoded  ATP-dependent  pump  that 
extrudes the toxic oxyanions from the cells (2). Thus, the 
intracellular concentration of the oxyanions never rises to 
toxic levels, hence  resistance. 
The ars operon has been cloned as a single 5068-bp’ frag- 
ment from the original  90-kilobase R-factor  into  small  mul- 
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ticopy plasmids (3). Analysis of the nucleotide sequence re- 
veals five genes,  two  regulatory (4)’ and  three  that encode the 
proteins that effect resistance to arsenite (antimonite) and 
arsenate (2). Of the five, the arsA and arsB genes  encode the 
subunits of the pump. The ArsA protein is physiologically 
part of a  complex  with the ArsB protein in the  inner mem- 
brane of E. coli (5). When overexpressed from multicopy 
plasmids,  the ArsA protein is found  predominantly  as a  sol- 
uble protein in the cytosol and is produced to -10% of the 
total cell proteins (6). The purified ArsA protein exhibits 
arsenite  (antimonite)-stimulated  ATPase  activity (6, 7). The 
extremely hydrophobic ArsB protein, located in the inner 
membrane of E. coli, serves as  the  membrane  anchor for the 
catalytic ArsA subunit and has been postulated to be the 
portion of the  pump  that  conducts  anions (2, 5). 
Previous attempts  to  express  the ArsB protein in amounts 
sufficient  for  biochemical analysis by increasing plasmid copy 
number or the  rate of transcription from  various promoters 
have been unsuccessful. The arsB gene is  transcribed  as  the 
middle reading  frame of a  polycistronic mRNA, with the arsA 
reading frame upstream and the arsC reading frame down- 
stream. However, the  amounts of ArsB protein synthesized 
are only a fraction of the ArsA and ArsC proteins. This 
differential translation correlates with degradation of the 
mRNA. It was found  from Northern  analysis  that  the operon 
was transcribed  initially  as a full-length 4400-nucleotide  RNA 
(8). The transcript was rapidly degraded to two species, a 
2700-nucleotide RNA  containing  the arsR and arsA sequences 
and a  500-nucleotide  RNA containing  the arsC sequence. The 
original transcript was cleaved within  the arsB sequence. The 
half-life of the 4400-nucleotide transcript was <4 min, 
whereas the half-lives of the 2700- and 500-nucleotide by- 
products were -10 min. Analysis of the arsB translational 
initiation region (TIR)  indicated possible formation a stable 
hairpin beginning with the  third codon of the arsB coding 
sequence. In addition, the second codon is not the most 
frequently utilized leucine codon (9). Either or both  factors 
could  produce pausing of the ribosome at  the  start of the arsB 
sequence. The downstream RNA would be relatively unpo- 
pulated  with ribosomes and  thus susceptible to endonuclease 
attack.  The  combination of inefficient translational  initiation 
of mRNA and a rapid loss of the arsB message could be 
responsible  for the low production of the ArsB protein.  This 
might be a general  mechanism by which cells prevent over- 
expression of membrane  proteins. 
Determination of the mechanism of the arsenical pump 
requires knowledge of the  structure  and  function of the ArsB 
protein. For biochemical studies,  the  protein  must be produced 
in  substantial  amounts by controlled  expression of the arsB 
gene. In  this  study, we report  the  functional overexpression 
of a  re-engineered  ArsB protein  as a chimera with the ArsA 
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protein. addition, we describe insights on difficulties and SK5671, and SG20043 were used to minimize degradation of DNA, 
solutions for the overexpression of membrane  proteins  in E.  used as host cell for gene cloning and DNA preparation. mRNA,  and  proteins, respectively. E. coli strain  HBlOl was mainly 
coli cells. DNA  Manipulations-The conditions for plasmid isolation,  DNA 
restriction endonuclease analysis, ligation, transformation, and se- 
Media and Growth Conditions-Cells were grown either in LB 
Materials-All restriction enzymes and nucleic acid-modifying en- medium (11) or, for E, coli strains T G ~  and ~ ~ 1 0 9 ,  in a basal salts 
zymes were obtained from Bethesda Research Laboratories. oligo- medium (10). cells were grown at 37 oc, unless otherwise noted, 
nucleotides were synthesized  in  the Macromolecular Core Facility of Antibiotics were added as required at the following concentrations: 
Wayne State University, School of Medicine. All other chemicals ampicillin, 100 ccg/ml; tetracycline, 25 ccg/ml; chloramphenicol, 35 
were  obtained from  co mercial  sources.  pg/ml; and  kanamycin,  45 pg/ml. Sodium arsenite was added at  the
Strains, Plasmids, and Phage-E. coli strains,  plasmids,  and phage indicated  concentrations  to  test for arsenical  resistance.  For cloning 
used in this study are described in Table I. E. coli strains  SURE,  with plasmid pUC19 as a vector in E. coli strain JM109, 50 pg/ml 5- 
EXPERIMENTAL  PROCEDURES quencing have  all  been  described (10). 
TABLE I 
Strains, plasmids, and  phage 
Strain/plasmid/ Genotype/description" 
phage 
Ref. 
SURE 
SG1 
SK5671 
JM107 
SG20043 
HBlOl 
pACYC184 
pJLA503 
pJLA504 
pJBS633 
pUM3 
pBMlOO 
pBMlOl 
pWSUl 
pBM200 
pBM202 
pBlOO 
pB200 
pB300 
pBLlO 
pBL2O 
pBL30 
pBL40 
pArsA 
pBClOO 
pHIN19 
pHINlOO 
pHIN2OO 
pJUN4 
ell-(mcrA), endA1, thi, relAl, gryA96, sbcC, recB, recJ, umaC::Tn5 
K12,  lac-proAB', supE, hsd-5, thi, F'(traD36,proAB,  lacIq,  AlacZM15') 
ams-I,  pnp-7, thyA715 
endA1, gyrA96, thi,  hsdRI7,  supE44,  rel41, lac-proAB', F'(traD36,proAB, 
laclq,  AlacZ-Ml5') 
lon-100, cps-3::TnlO, proCYC221 
supE44,  hsd20(r& mi),  recAl3, ara-14, proA2, lacYI, galK2,  rpsL20 
Tc', Cm', low-copy number vector 
Ap', temperature-inducible expression  vector with X p ~ / i p ~  romoters  and 
Ap', pJLA503  with  different  linker 
Km', Tc', blaM  fusion  vector 
arsABC genes of R773  cloned into  HindIII  site of pBR322, As' 
Complete ars  operon cloned into  EcoRI  and  HindIII  sites of pBR322, As' 
224-bp SphI-Csp45I  fragment  containing  mutated  arsBl gene without 
arsB  TIR cloned into  SphI-Csp45I-digested pBR322, Ap',  As" 
SphI-BstXI  fragment  containing  first 39 bp of arsBl  from pBMlOO sub- 
cloned into  SphI-BstXI-digested  pUM3  to replace arsA gene and  same 
portion of arsB gene, Ap',  As" 
cloned into  SphI-EcoRI-digested pBR322, Ap',  As" 
mutated  arsB2 gene inserted  into  SphI-BstXI-digested  pUM3, Ap',  As" 
into  SphI-EcoRI-digested pJLA504, Ap',  As" 
into  SphI-EcoRI-digested pJLA504, Ap',  As" 
YDVPDYA) of influenza virus  linked  to  5'-end of arsB2 gene in 
(Km'), uurC 
atpE leader 
2492-bp SphI-EcoRI  fragment  containing multiply mutated  arsB2 gene 
SphI-BstXI  fragment from pBM2OO containing  first 39 bp of multiply 
2492-bp SphI-EcoRI  fragment  containing  arsBl gene of pBMlOl cloned 
2492-bp SphI-EcoRI  fragment  containing  arsB2 gene of pBM202  cloned 
Oligonucleotide encoding  sequence for 9-amino acid HA1  sequence  (YP- 
pJLA503, Ap',  As" 
2858-b~  EcoRI-SSDI  fraement  encoding  first  51 residues of wild-twe  arsB 
gene-fused with'blaMgene, Km', Ap'(arsenica1-inducible) 
1790-bp SspI  fragment  containing  first  51 residues of arsBl gene from 
plasmid pBlOO fused with blaM  gene, Km',  Ap' (temperature-inducible) 
1790-bp SspI  fragment  containing  first  51 residues of arsB2 gene  from 
plasmid pB200  fused with blaM  gene, Km', Ap' (temperature-inducible) 
2513-bp EcoRI-Ssp1  fragment  from  plasmid  pJUN4  cloned  into  EcoRI- 
PuuII-digested  pJBS633  to  create  ternary fusion  gene arsA-arsB2- 
blaM, Km',  Ap' (arsenical inducible) 
2408-bp HindIII  fragment  containing arsA gene  cloned into  HindIII- 
digested pACYC184, Cm' 
681-bp PstI fragment deleted from arsA gene of plasmid pWSUl  (arsBC). 
pUC19 with  deletion of sequence AGCT from multiple  cloning  site, Ap' 
2492-bp' SphI-EcoRI  fragment  containing  arsBl gene from  plasmid 
pBlOO cloned  into  inserted  SphI-EcoRI-digested  pHIN19, Ap' 
2492-bp SphI-EcoRI  fragment  containing  arsB2 gene from  plasmid 
pB200  cloned into  inserted  SphI-EcoRI-digested  pHIN19, Ap' 
2498-bp SphI  (blunt-ended)-Sal1  fragment  containing  arsB2 gene  from 
plasmid pB200  cloned into  plasmid  pWSUl  that  had been  digested 
with  BamHI,  blunt-ended,  and digested with  BamHI  to  create  arsAB2 
fusion  gene, Ap' 
I. 
Stratagene 
Amersham  Corp. 
44 
39 
48 
10 
46 
15 
15 
45 
3 
12 
This  study 
This  study 
This  study 
This  study 
This  study 
This  study 
This  study 
This  study 
This  study 
This  study 
This  study 
This  study 
This  study 
This  study 
This  study 
This  study 
This  study 
M13 mCM6-d6-37 M13 phage carrying wild-type ars genes with  Bal-31  deletion of arsA gene  4 
"Tc, tetracycline; Cm, chloramphenicol; Ap, ampicillin; Km, kanamycin; As, oxyanions of arsenic and antimony. Superscripts s and r 
indicate  sensitivity  and  resistance, respectively. 
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bromo-4-chloro-3-indolyl  6-D-galactoside and 45 pg/ml isopropyl-l- 
thio-P-D-galactopyranoside were added to  solid  media. 
Mutagenesis by Polymerase Chain Reaction-For creation of mu- 
tated arsB genes, the  targeted  DNA  fragments  from  positions -10 to 
282 of the arsB gene were enzymatically synthesized by polymerase 
chain reaction (PCR)  (13).  Phage M13mCM6-d6-37 carrying  the wild- 
type arsB gene was used as  the  template DNA (4). Oligonucleotides 
PCRlO  and PCR2O (Table 11), which  hybridize to  the  opposite  strands 
around  the  initiation region of the arsB gene, were used as  the  primers 
t o  amplify the  flanked region. Oligonucleotide PCR2O was designed 
to  create an SphI site at  the  start of the arsB gene and  to  change  the 
second codon to  the most frequently utilized leucine codon (CUG) 
(9). The arsB gene containing  the  mutations  introduced  with oligo- 
nucleotide PCR2O is designed arsB1. The 240-bp products of PCR 
were  digested with  restriction  endonucleases  SphI  and Csp45I. The 
resulting 224-bp  SphI-Csp45I fragment was  purified from a 3% aga- 
rose gel and ligated into  SphI-  and Csp45I-linearized plasmid  pUM3. 
The  junction  fragments were further amplified  by PCR using oligo- 
nucleotides PCRlO  and  PCR30  as primers. Oligonucleotide PCR3O 
(Table 11) was designed to add additional mutations to the arsBl 
gene to destabilize the predicted secondary structure in the arsB 
mRNA.  The  additional  mutations were created  in  the  GC-rich  stem- 
loop between the third and twelfth codons of the arsB gene. The 
multiply  mutated arsB gene is  designated  arsB2. For PCR,  the  series 
of cycles of template  denaturation a t  95  "C for 1 min,  primer  anneal- 
ing  at 50 "C for 1 min, and  extension by Taq polymerase a t  74 "C for 
1 min was automatically  performed using  a  TwinBlock PCR  system 
(Ericomp,  Inc.). 
DNA Sequencing-All mutations were verified by dideoxy sequenc- 
ing  (14).  The two  differently mutated 224-bp SphI-Csp45I  fragments 
from  the  PCR  reactions were cloned into  plasmid pUM3. The result- 
ing plasmids, pBMlOO ( a r s E l )  and pBM2OO (arsB2), were digested 
with  SphI  and EcoRI and ligated into  plasmid pJLA504 (15) which 
had been linearized with the same enzymes. The double-stranded 
DNAs from the  resulting  plasmids, pBlOO (ar sB l )  and pB200 
(arsBS), were directly  sequenced  using  a Sequenase  reagent  kit  (ver- 
sion 2,  U. S. Biochemical  Corp.). 
Construction of Recombinant pJUN4 Plasmid-A 135-bp BstXI- 
SalI  fragment  bearing  the multiply mutated region of the arsB2 gene 
from pBM2OO was purified and ligated into  plasmid  pUM3  partially 
digested  with  SalI  and  BstXI, replacing the  corresponding  portion of 
the wild-type arsB gene with  the  mutated gene. The resulting plasmid, 
pBM202, was digested with  SphI,  blunt-ended  with S1 nuclease, and 
then digested with  endonuclease  SalI.  The  resulting 2498-bp blunt- 
ended  SalI  fragment, which contained  the  entire  mutated arsB gene 
except for the  initiating  ATG, was ligated into  plasmid  pWSU1 which 
had been digested with SalI, blunt-ended with S1 nuclease, and 
further digested with  BamHI.  The  resulting plasmid, pJUN4,  con- 
tained  the  arsB2 gene  fused with  the  first 1458 bp of the arsA gene. 
The resulting  arsAB2 gene  fusion would utilize the efficient TIR of 
the arsA gene. 
Construction of lacZ-arsB Fusions-Plasmids pBlOO and pB200, 
containing  the  mutated arsBI and  arsB2 genes, were digested with 
SphI  and EcoRI. The 2492-bp SphI-EcoRI  fragments were subcloned 
into  plasmid  pHIN19.  Each  mutated arsB gene was fused in  frame  to 
the  first 12 bp of the lacZ gene, under  control of the lac promoter. 
The resulting plasmids, pHINlOO (arsBI)  and pHIN200 (arsB2), 
were designed to use the lacZ translational initiation region for 
translation of the arsB gene. 
Construction of HAl-arsB Fusion-Complementary oligonucleo- 
tides HAlOO and HA200, containing  the  corresponding sequence of 
hemagglutinin of the influenza virus (16), were annealed by heat 
treatment  at 90 "C for 2 min  and  then cooled at  4 "C for a t  least 30 
min. The annealed oligonucleotides were separated  and purified  from 
a 7% polyacrylamide gel and ligated into  plasmid  pUM3 at  the  NdeI 
and  KpnI  sites.  The  resulting 753-bp SphI  fragment was ligated into 
plasmid pBM202 at the  SphI site. The 2525-bp  NdeI-EcoRI fragment 
from  the  resulting  plasmid was then ligated into NdeI-EcoRI-digested 
plasmid pJLA503, creating  plasmid pB300. This would allow expres- 
sion of the  mutated arsB2 gene  fused with  the  HA1  epitope  in plasmid 
pB300 under  the  control of tandem X ~ L  and Xp, promoters  and would 
utilize the efficient atpE TIR (15). 
Construction of arsB-bla Fusions-The 2858-bp EcoRI-Ssp1  frag- 
ments  from  plasmid  pWSU1,  containing  the ars promoter region and 
the  first  153  bp of the wild-type arsB gene, were ligated into EcoRI- 
PuuII-digested  pJBS633  to  create  an  in-frame arsB-bla  fusion gene. 
In  the  same way, the 1790-bp Ssp1  fragments from plasmids pBlOO 
and pB200, containing  the  first  153  bp of the  mutated arsB genes 
under the tandem XpLR and X p R  promoters and atpE leader from 
pBlOO and pB200, were ligated into the PuuII site of pJSB633 to 
create blaM fusions  plasmids pBL2O and pBL30,  respectively. Tran- 
scription was regulated  from the  temperature-sensitive cI857 repres- 
sor  on  the  same plasmid. 
A ternary fusion (17) was constructed to  put  the blaM reporter 
gene at  the 3'-end of the binary arsAB2 fusion described above. 
Ternary fusion plasmid  pBL40  (arsA-arsB2-blaM) was constructed 
from  plasmid  pJUN4  and  contained  the  first 1458 bp of the arsA gene 
fused to  the  first 150 bp of the  arsB2 gene, in  turn fused to  the coding 
region of the  mature blaM gene. 
Polyacrylamide Gel Electrophoresis and Immunological Blotting- 
TABLE I1 
PCR oligonucleotides 
Oligonucleotides Length Sequence (5' + 3')" Commentsb 
nt' 
PCRlO 21 CAGCAGGCGGCCACGACCGTT Complementary  to n t  
261-282  of arsB coding 
sequence 
+17 of arsB nucleotide 
sequence 
PCR20 27 AGGAGGTTgATGCCTGGCAGGAGC Corresponds  to  nt-10  to 
PCR30 42 ATGGTGCATGCTGCTGGCGGGCGCCATTTTTATTTTTATTCTGACCAT nt 1-7 are  complementary 
to  seauence  in ~ B R 3 2 2  
HAlOO 43 
tet gene; nt  8-42 corre- 
spond  to n t  1-35 of 
arsB coding  sequence 
TATGTACCCATACGATGTTCCGGATTACGCTGGCATGCGGTAC n t  1-4 generate  NdeI  site 
and  initiation codon; nt  
5-31 contain coding se- 
quence  for HA1 epi- 
tope; nt  32-34 contain 
glycine codon and serve 
as linker; nt  35-43 
serve as linker for SphI 
and  KpnI  sites for clon- 
37 CGCATGCCAGCGTAATCCGGAACATCGTATGGGTACA 
ing of arsB2 gene 
HA200 Complementary  to HA100 
' The nucleotides that  are  different  from  the wild-type ars sequence are  underlined. 
The A of the  initiating codon ATG of the arsB gene is  designated  as +1. 
nt, nucleotides. 
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Samples were prepared by heating to 90 "C in SDS sample buffer for 
2 min. SDS-polyacrylamide gel electrophoresis (PAGE) was per- 
formed as described (18). lmmunoblotting was performed by electro- 
phoretic  transfer of the proteins to nitrocellulose (0.2 pm) for 18-24 
h at 25 mV at 4 "C. Unoccupied sites on the nitrocellulose filter were 
blocked using 5% nonfat dried milk in phosphate-buffered saline (21 
mM KH,PO,, 11 mM Na2HP04.7Hz0, 0.138 M NaCl, 2.5 mM KCl, 
pH 7.4). The filter was incubated with rabbit antisera for 1 h and 
washed three  times for 10 min each time with 15 ml of phosphate- 
buffered saline containing 5% dried milk, all at 37 "C. To detect the 
antigen-antibody complex, the filter was incubated with goat anti- 
rabbit IgG (1:3000) t.o which horseradish peroxidase was conjugated. 
The filter was incubated with the conjugated second antibody for 1 h 
at 37 "C and washed three times with 15 ml of phosphate-buffered 
saline. Hydrogen peroxide (0.03%) and  ~-chloro-l-naphthol (3 mg/ 
ml) were added in phosphate-buffered saline to produce a color 
reaction. 
Membrane Binding of ArsA Protein-Partially purified ArsA pro- 
tein was added to membrane vesicles (1 mg  of membrane protein) in 
an assay mixture containing 25 mM Tris,  pH 7.5, and 0.2 M potassium 
chloride in a t.otal  volume of 0.2 ml, The assay mixture was incubated 
a t  room temperature for 20 min. To remove unbound ArsA protein, 
the mixture was diluted 10-fold with a solution of 10 mM Tris, pH 
8.0, 20% glycerol, and 0.2 M potassium chloride; pelleted by centrif- 
ugation at  100,000 X g for 1 h and washed once in the same buffer. 
The membranes were suspended in 0.1 ml of SDS sample buffer and 
incubated at 90 "C for 5 min. Samples (10-20 pl) were analyzed by 
SDS-PAGE on 10% acrylamide gels.  Five concentrations of purified 
ArsA protein were  used to construct  a standard curve. The proteins 
were immunoblotted using anti-ArsA serum (1:lOOO). The intensities 
of the color reactions on the  nitr~ellulose were analyzed by scanning 
the images with a  Hewlett-Packard Scanjet. Plus  scanner and quan- 
tifying with a densitometric program (Strat,agene). The standard 
curves generated with purified ArsA  were used to calculate the 
amounts of the ArsA protein in the gels. The standard curve was 
linear t.o 150  ng of  ArsA protein. 
Alkaline ~ ~ a c ~ ~ o n a t ~ o ~ - A l k a l i n e  fr ctionation of membranes con- 
taining  the overexpressed chimeric ArsAB2 protein was performed 
by a modification of the method of Ito and Akiyama (19). Cultures of 
E. coli HBlOl hearing plasmid pJUN4 were induced at an A550 of 0.45 
with 0.1 mM sodium arsenite for 10-120 min as indicated in the 
legend to Fig. 4. After induction, the cultures were each diluted to  an 
Asso  of 0.45 to give a  constant number of cells for analysis. The cells 
from 20 ml of each culture were pelleted; suspended in 0.1 ml of a 
solution of 10 mM sodium phosphate buffer, pH 7.8, containing 1 mg/ 
ml lysozyme, 5 mM EDTA, and 7 mM 8-mercaptoethanol; and incu- 
bated for 10 min on ice.  Cycles of quick freezing and thawing were 
repeated until the suspension clarified. The suspension was mixed 
with 0.1 volume of  cold 0.1 N Na,COs, mixed, and immediately 
centrifuged at 10,000 X g at 4 "C  for  10  min. The  supernatant solution 
was neutralized with 0.1 volume of 0.5 N phosphoric acid. Equivalent 
amounts of t.he supernatant solutions and pelleted materials (-30% 
of the starting  materialflane) were analyzed by polyacrylamide gel 
electrophoresis (Fig. 4). 
Separation of Inner and Outer Membranes-Cultures of E. coli 
HBlOl  (pJUN4) were induced with 0.1 mM sodium arsenite for 10 
min. The cells were pelleted and gently suspended in an ice-cold 
buffer consisting of 10 mM Tris-HC1, pH 8.0, containing 0.75 M 
sucrose. Lysozyme  was added to 0.1 mgfml, and the suspension was 
incubated for 30 min at 4 "C. The suspension was then diluted with 
2 volumes of 5 mM disodium EDTA, pH 7.5, and lysed by a single 
passage through a French pressure cell at 20,000 p s i .  The lysate was 
centrifuged at  10,000 X g for 20 min. The  supernatant solution was 
further centrifuged at 100,000 X g for 1 h ta isolate total membranes. 
Total membranes were separated into inner and outer membrane 
fractions by suspension in an unbuffered 25% (w/w) sucrose solution 
containing  5 mM disodium EDTA, pH 7.5 and layered onto  a  contin- 
uous sucrose gradient (25-45%) that had been prepared by five cycles 
of rapid freezing and thawing. Following centrifugation at  110,000 x 
g for 16 h  in  a swinging bucket rotor, two bands were obtained. The 
upper  and lower hands represented the cytoplasmic and outer mem- 
brane fractions, respectively (20). When the chimeric ArsAB2 protein 
was large and diffuse. 
was expressed at high levels, the upper band of the  inner membrane 
Detection of Inclusion B~~es-Inclusion bodies formed by overex- 
pression of the arsAR2 gene were isolated by a modification of the 
procedures of Marston (21) and of Kleid et al. (22). Cells of E. coli 
HBlO1 (pJUN4) were harvested after 60 min of induction with 0.1 
mM sodium arsenite. The cells were converted to spheroplasts by 
suspension in 0.1 volume of a buffer consisting of 10 mM Tris-HC1, 
pH 8.0, containing 0.1 M NaCl, 1 mM disodium EDTA, and 1 mgfml 
lysozyme for 30 min at 23  "C. The spheroplasts were  lysed with 0.2% 
sodium deoxycholate, and DNA was digested with 10 pg/ml DNase I. 
The inclusion bodies  were isolated by centrifugation at 10,000 X g for 
10 min and analyzed by polyacrylamide gel electrophoresis and im- 
munoblotting. 
tJptake of 73AsO~-Accumulation of 73AsO; in the cells was per- 
formed as described previously (23). All procedures were performed 
at room temperature.  Stationary phase cells  from 200 ml of culture 
medium were pelleted and suspended in 1 ml of a triet,hanolamine- 
buffered minimal medium (24) containing 10 mM glucose, 5 mM KC1, 
1 mM sodium arsenite, and 1.25  pCi  of  73AsO;. Portions of the 
suspension were filtered through nitrocellulose filters (0.45-pm pore 
size; Whatman)  at intervals. The filters were  washed with 5 ml of the 
same buffer, dried, and quantified by liquid scintillation counting. 
RESULTS 
Attempts a t  Expression of Re-engineered arsB Genes-The 
wild-type arsR gene of R-factor R733 was subcloned, mutated, 
and fused  with the arsA gene as outlined  in Fig. 1. To permit 
subcloning of the arsB coding  sequence, a Sph.1 site 
(GCATGC~ was created at the  initiating codon by PCR. In 
the same process, the second codon, UUA for leucine, was 
changed  to  the more frequently utilized codon CUG (9). Using 
the newly created  unique  SphI  site,  the  mutated  arsB1 gene 
S,,j 
EOORI 
RntHl  
FIG. 1. Schematic representation of cloning strategy em- 
ployed for construction of plasmids for overexpression of 
ArsB  protein.  The restriction sites required for cloning are shown. 
The 4.3-kilobase HindIII fragment containing the wild-type arsB 
gene was originally isolated from R-factor R773 as described under 
"Experimental Procedures." The black segments illustrate the oligo- 
nucleotides used for mutation of the  arsB gene (for sequences, see 
Table 11). Ap, ampicillin; Tc, tetracycline. 
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FIG.  2. Translational initiation region of arsB gene. The primary and proposed secondary structures are shown. The putative 
rit~osome-hinding sequence (Shine-I)algarno (SI))) and the AUG initiation codon of the nrsN gene are undcrlincd. The thermodynamic 
stnhilities are cdrrllnted according t o  'I'inoco et 01. (47)  and are expressed as the free energy of the secondary hairpin strrrrtnrrs. The 
mutational  sut~stitution  of  I~ases  surrounding  the AlrG codon  are  indicated by the nrrou's. as are the  t~ase pairs  forming  the  stem-loop.  The 
NHy-terminal amino acid secluence of the nrsH gene prodrlct is given below the mRNA sequence. The site in nrsH that was fused t o  the 
upstream nrsA gene is indicated ( n r r m t ~ ) .  
was  cloned  int,o  expression  vector  pJLA504  under  control of 
the s t rong hpl, and hp,, promoters and t.he efficient atpE 
leader,  creat.ing  plasmid pH100. In  this  plasmid,  transcription 
from  the h promoters is regulated  hy t,he temperature-sensi- 
tive  cI857  repressor.  Plasmid  pdLA504  has  been  used  success- 
fully  for  high level expression of a  number of genes  following 
a temperature shift. to 42 "C (15). Plasmid pRlO0 (arsRI), 
with  a wild-t.ype arsA gene  expressed  in  trans  from  the  com- 
patible  plasmid  pArsA,  exhibited  arsenite  resistance;  but  the 
level of resist.ance  was  variable,  and  the  plasmid  was  unstable. 
T h e   a r s R I  gene WAS further  mutated  by  PCR to destabilize 
t h e  GC-rich  stem-loop  between  the  t,hird  and  twelfth  codons 
of  the  arsH  gene  (Fig.  2).  It  should  be  not.ed  that  none of the  
mutations in t.he arsR1 or arsR2 genes changed the amino 
acid  sequence of the  ArsR  protein.  Cells  expressing  the  arsR2 
gene  from  plasmid  pR200  with arsA in  trans  showed  the  same 
properties as cells  with  pR100.  In  neither  case  could  a  band 
corresponding to the  ArsH  prot,ein  be  detected  on  silver- or 
Coomassie  Blue-stained SDS gels of induced  cells  (data  not 
shown). 
T h e  st,rong Xp, and hpl. promoters,  like ptW, are  leaky  and 
produce  plasmid  instability  due to the  high  levels of transcrip- 
tion  (25).  Likewise,  when  the  mutated  arsH1  and  arsR2  genes 
were put under the control of the lac promoter (plasmids 
pHINl0O (arsR1) and pHIN200 (arsH2)), no ArsR protein 
was  observed  on  SDS-PAGE of induced  cells  (data  not 
shown). 
Gene  fusions  using  a  5"sequence  for  a  %amino  acid  peptide 
corresponding  to  an  epitope of hemagglutinin  (HA1) of t h e  
influenza virus have been useful for identification of mem- 
brane  proteins  (16).  A  linker  composed of the  complementary 
oligonucleotides HA100 and HA200, encoding the HA1 epi- 
tope,  was  fused 5' to the  arsR2  gene  in  plasmid pR300. T h e  
resulting  HAI-arsH  fusion  gene  conferred  arsenite  resistance. 
However,  the  chimeric  protein  was  not  synthesized  in  large 
enough quantities for detection hy immunoblotting using a 
monoclonal  antihody  against  the  %amino  acid  epitope,  and  a 
band  corresponding to the  chimera  could  not  be  detected  by 
SDS-PAGE  (data  not  shown). 
Expression of Functional arsAR2 Gene-With the same 
rationale  as  descrihed  above,  the  arsR2  gene  was  fused 3' in 
frame  with  t.he  first  1458  bp of the  arsA  gene.  The  fusion  gene 
would  encode  a  914-residue  polypept.ide,  with  486  residues of 
t,he  ArsA  protein  and  428  residues of the  ArsR  protein.  The 
polypept,ide would cont,ain the entire ArsR sequence except 
for the  init.iating  methionine.  The  fusion  gene  was  regulated 
FIG. 3. Overexpresnion of chimeric arnAB gene  product. F;. 
coli HRlOl cells carrying plasmid p.Jl'N.4. which contains the chi- 
meric nrsAR2 gene, were grown as descrihed rlnder "Rxperimental 
Procedures."  IVhen  the  culture  reached nn A,,4, of 0.5, sotlirrm arsenite. 
(0.1 mM) was  added, and the  culture was incrrh~ted for an additional 
60 min. A. cells were lysed in SI)S sample htrffer. Equnl amounts o f  
protein (75 pg) were  separated  hy SI)S-I'A(;I.: and stained  with 
Coomassie Rlrle. l 4 n e  I ,  molecular mass standards; lnnrs 2 and ti. 
cells with  vector (pHR322); lnnrs :I and 7, cells  with pl:\l:! t n r . s A M ' ) :  
lanrs 4 and H ,  cells with pJLJN4 (ar.sAH2): lnnc 5 .  prlrified Arsh 
protein; lnnrs 2-4, unindured; lnnrs 6-8. induced. N. immunohlot 
analysis of the overproduced  chimeric ArsAI32 protein. A polyclonal 
antiserum  prepared  against prrrilied ArsA protein was usrd. The. 
contents of each  lane  are  the same as descrihed for A .  
by  the  endogenous  ars  promoter.  When  induced  with 0.1 mM 
sodium  arsenite,  the  chimeric  protein  was  produced at -15- 
20% of the  total  membrane  protein  (Fig. 3). T h e  fusion  protein 
migrated  at  a position corresponding to a mass of approxi- 
mately 80 kDa  on SDS-7% polyacrylamide gels And reacted 
with  polyclonal  antibodies  against  the  ArsA  protein.  This is 
somewhat lower than the predicted mass of 97.976 Da, hut 
the  native  ArsR  protein  migrates  faster  than  expected  on  the 
same gels (26). Anomalous migration of membrane  proteins 
has  been  observed  with  other  membrane  proteins  and  could 
be  due  to  binding of large  amounts of SDS. 
Since  antibodies  to  the  ArsH  protein  have  never  been 
obtained,  the level of expression of the  arsH  constructs  was 
determined  with  antibodies  to  [j-lactamase  as  a  reporter  group 
using  a  series of blaM  gene  fusions.  Three  hinary  nrsR-hlnM 
fusions  were  created  with  either  the  sequence of the  arsH  gene 
encoding  the  first 51 residues of the wild-t.ype ArsR protein 
(pRL10) or the  corresponding  regions of the  orsH1 (pH120) 
or arsH2 (pRL3O) gene.  A  ternary  fusion  was  constructed hv 
fusingthearsAH2geneofpJUN4 with  the  hlnMgene,crenting 
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plasmid pHIA0. The amount of anti-/3-lactamase-reacting 
material produced hy cells expressing each of the chimeras 
was compared using immunohlotting. The results demon- 
strate that the [j-lactamase moiet,y of t,he ternary fusion is 
produced  in  at  least  100-fold  greater  amounts  than  any of the  
ot.her  construct,s. Fig. 4  illustrates  the level  of expression  with 
a comparison of immunodot  blots  from  cells  expressing  the 
arsH-hlaM and a d - a r s R 2 - h l a M  fusion  genes. 
Effect of Expression o f  arsAH2 Grne on Cell Growth-In 
some  cases,  att.empt.s to express the genes for memhrane 
proteins  at  high  levels  cause loss of viability (28, 29). In  other 
cases,  membrane  proteins  can  he  produced  in  high  amounts 
with  little  deleteriouseffect  on  cell  growth (27,30,31). Growth 
of  cells  expressing  the arsAR2 fusion  gene  was  inhihited  hv 
overexpression of the  chimeric  ArsAR2  protein  (Fig. S A ) .  In 
spit.e of  t.he decrease  in  growth  rate,  the  culture  density  after 
overnight  growth  was  not  decreased,  suggesting  that  produc- 
tion of the  chimeric  protein is not  toxic. 
Cellular Localization of Chimeric ArsAR2 Protcin-Integral 
memhrane  proteins  are  not  extracted  into 0.1 M sodium 
bicarbonate,  whereas  peripherally  hound  proteins  are (19). E .  
coli cells hearing pdUN4 were induced with arsenite in the 
logarithmic  phase of growth as descrihed  under  "Experimental 
Procedures."  From  the  time  course of induction,  the  chimera 
appeared  in  <I0  min  and  reached  maximal  induction  within 
50 min. A t  various  times  following  induction,  intact  cells  were 
extracted  with 0.1 M sodium hicarhonate, and the alkali- 
soluble  and -insoluble fractions  were  analyzed  hy  SDS-PAGE 
(Fig. 5 ,  R and C). The chimeric ArsAR2 protein was found 
primarily  in  the  alkali-insoluble  fraction,  indicating  that it is 
a n  int,egral  memhrane  protein.  Washing  the  memhranes  with 
urea  to  remove  extrinsically  hound  proteins  did  not  remove 
the  chimera,  again  indicating  that it is an  integral  memhrane 
protein (Fig. 6 A ) .  Total  memhranes  containing  the  ArsAR2 
protein  were  fractionated  into  inner  and  outer  membrane  hy 
isopycnic centrifugation as descrihed under "Experimental 
Procedures," and the memhrane fract.ions were analyzed hy 
SDS-PAGE  and  immunohlotting  (Fig. 6, H and C). T h e  
ArsAR2  protein  was  found  only  in  the  inner  membrane  frac- 
tion  (Fig. 6, R and C). When  the  chimeric  protein  was  maxi- 
mally  induced,  inclusion  hodies  containing  the  chimera 
formed.  This  form of the  protein  could  he  solubilized  with 4 
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Flc:. 4 .  Comparison  of  expression of arsAR2 gene with arsB 
gene. Cells o f  E. rnli 'I(i1 bearing plasmid p111,4(1 (ternarv nrsA- 
nrsH2-blnM fusion)  or pHI,10 (hinary orsH-blnM fusion)  were  grown 
as descril)ed  under  "Experimental  Procedures."  The cells were solu- 
bilized with 0.5";. SIX, and the extracts were vacuum-l)lotted onto 
nitrocellrrlose memhranes  and  immunodetected  with  antiserum  to /j- 
lactamase ( A  ). In 13, the  amount of antigenic  material  was  quantified 
by densitometry  (Stratagene). 
L 
M urea (Fig. 6A ). A similar phenomenon has hren ohsewed 
with  the  lactose  permease (32). 
ArsAH2 I'rotrin Is Ihnctionol-The  functional state o f  the 
chimeric  ArsAR2  protein was investigated in three  ways.  First. 
its ahility to confer arsenical resistance was cletermined. A s  
described  ahove,  expression of the arsAHP genr is not  lethal, 
even  though it decreases  the  growth  rate.  Arsenical  resistance 
requires  expression of only  the arsA and orsf< genes ( 3 3 ) .  T h e  
chimera,  which  contains  the  entire  ArsH  protein  and a portion 
of the ArsA protein, is unahle to confer resistance hy itself 
(Fig. 7.4) .  When a wild-t-ype arsA gene was coexpressed  from 
a compatihle  plasmid,  the  cells  were  resistant to arsenite. 
T h e  second  measure of function of the  chimeric  protein is 
its  ahilitv to catalyze  arsenite  extnlsion.  Exclusion of arsenite 
from  cells  in  an  uptake  assav  reflects  extrusion  activity (23 ) .  
The  uptake of arsenite  hv  intact  cells  expressing  the  orsAN2 
gene  was  examined  using '"AsO, (Fig. 7 I j ) .  \Vhen  expressed 
either  alone or in  trans  with a wild-type  ar.4  gene,  the  fusion 
gene  conferred  the  ahilitv to exclude arsenite. I t  is not clear 
whether  the  transport  activity of cells  with  the nrsAI<2 gene 
alone requires the remaining portion of the ArsA protein. 
Some  arsenite  extrusion  has  heen  ohserved  in R .  coli cells  that 
have  only a wild-t?rpe nrsH gene  from  either  plasmid K773 nr  
p1258 without  an arsA gene," so it is not  surprising  that  cells 
with  onlv  the arsAR2 gene  exhihit  a  similar  property. I t  may 
be  that  the  ArsR  protein  can  function as a secondary  porter 
in  the  ahsence of the  catalytic  ArsA  protein.  Alternatively, a 
chromosomally  encoded  ATPase  may  substitute  fnr  the ArsA 
protein. These possihilities are under investigation. In any 
case, these results demonstrate that the ArsAH:! protein r r -  
tains  its  resistance  and  transport  functions. 
Third,  the  ahility of the  chimeric  ArsAH2  protein t o  hind 
S. Dey, D. Dou. (;. . J i ,  S. Silver. and 13. 1'. Rown.  rnanwrripr in 
.~ ~ ~~ ~~ 
preparation. 
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FIG. 6. Cellular  localization of overexpressed  chimeric 
ArsARP protein. A ,  immunohlot of an SDS gel Vi acrylamide) of 
cells fractionated into the cytosol (lanr 2) ,  total memhranes (lanr 3 ) .  
and inclusion hodies ( h n r  8). The membranes and inclusion bodies 
were extracted with urea at concentrations of 2 M ( h r s  4 and 9). 4 
M (lanrs .5 and IO), 6 M (lanrs 6 and 1 1 ) ,  and 8 M (lanr 7 and 12). 
Urea extraction was performed for 60 min for memhranes and for 30 
min for inclusion bodies at 4 "C, and the suspensions were centrifuged. 
The pelleted material from the membranes and the urea-solubilized 
material from the  inclusion bodies were analyzed by immunohlotting. 
H ,  total membranes were fractionated into  inner (lanr 14)  and outer 
( lanr  l Q 5 )  membranes by sucrose gradient centrifugation. The mem- 
brane fractions were analyzed by SDS-PAGE (7% acrylamide) and 
stained with Coomassie Blue. C ,  the proteins from H were immuno- 
blotted. 1,anr.s 17-19 are the same as lanrs 14-16 in R. Lanes I .  16. 
and 19 contain purilied ArsA protein (2  pa). l.unr 13 contains protein 
standards. Immunohlotting was performed with anti-ArsA serum. 
I'olyacrylamide gels were 7% acrylamide. 
purified ArsA protein in vitro was examined (Fig. 7C). T h e  
amount of ArsA prot.ein  hound  to  everted  membrane  vesicles 
(1 mg of membrane  protein)  prepared  from  cells  expressing 
t h e  chimeric ArsAH2 protein  from  plasmid pJUN4 was  con- 
siderably  higher  than  the  amount  hound to membranes  pre- 
pared from cells expressing the wild-type arsR gene from 
plasmid pRC100 (Fig. 7C), although  not  the  100-fold  increase 
that  might  have  been  expected  from  the  data  in Fig. 4, 
suggesting  that  only  a  portion of the  ArsAB2 protein  may  he 
functional. 
DISCUSSION 
There are numerous gene products of biological interest 
that  cannot  be  obtained  from  the  natural  sources  in  quantities 
sufficient for detailed biochemical and biophysical analysis. 
T h e  levels of many  soluble  proteins  have  been  increased to 
the  point  at which  they  become  the  predominant  protein  in 
t h e  cell simply by expressing the respective genes in high- 
copy  number  plasmids or behind  strong  promoters.  Since  the 
inner membrane of E .  coli has a more limited volume than 
t h e  cytosol,  membrane  proteins  are  frequently  more  difficult 
to produce  in  large  quantities  than  are  soluble  proteins (34). 
Some  membrane  proteins  have  been  produced  in  amounts 10- 
50-fold  higher  than  normal,  including  the E. coli D-lactate  and 
N A D H  dehydrogenases (35) and  the E .  coli lactose  permease 
(32). Some  memhrane-bound  complexes  could  be  produced  in 
amounts  rivaling  the  most  highly  produced  soluble  proteins, 
for example,  fumarate  reductase (30). In  that  case,  there  was 
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FIG. 7. Riological activity of ArsARP prote!n. 'The function 
o f t h e  clrsAH2 fusion gene in arsrni t r  resistanre  and 'AsO; exclusion 
f rom t,'. coli cells W R S  analyzed. A .  arsenite resistance. Overnight 
cultures o f  t,' r ~ l i  strain HHIOI  cilrrying plnsmids wcre t l i l~~tet l  .-dl- 
fold i n t o  1.13 medium rontnining t h e  indicated rcrncentr ;~t i~~ns ( I !  
sodiunl arsenite and incubated at 117 "(' with shaking for 20 h. I n  I < .  
cells were grown in enriched medium and nssayrd fllr :tccumuI:ltion 
o f  "AsO; as described under "F:xperinwntal l~r~rrclurw." I n  .,I i ~ n d  
H ,  cells had the following plasmids: 0. p H W 2  lvector): 0. p I ' \ l : {  
(nr.s.4 arsH): *, pJIIN.4 (arsAH2):  A. pArsA inrs.4); .. p,JI.S4 + 
pArsA (arsA + nrsAH2).  In  ('. t h e  8 m o u n t  ( I !  purilietl ArsA p r ~ ~ t e ~ n  
bound t o  everted membrane vesicles from cells expressing p lasn l id  
pHCIOO ( a r s H )  (left) or pJUN4 (n rsAH2)  ( r ich! )  WIIS tletrrminetl :IS 
descrihcd under "Experimental I'roredures." 
a concomitant increase in phospholipid production, so that  
the  extra  protein  formed  cytosolic  phospholipid-protein  struc- 
tures,  circumventing  the  problem of the  two-dimensional  na- 
ture  of the  inner  membrane (36). In  each  case,  the  increase 
in  membrane  protein  production  resulted  from  increasing  the 
rate of transcription by the use of multicopy vectors and 
strong  promoters. 
However,  ot,her  membrane  proteins  are  refractory  to  over- 
production. Increasing the copy number of the tetracycline 
transporter encoded by transposon TnlO (Class H t c t )  re- 
sulted in lower levels of resistance to tetracycline than did 
strains hearing the same let gene in a low-copy state ( 3 7 ) .  
Thus, raising transcriptional rates through gene dosage o r  
promoter  control is not a universal  solution  to  the  prohlem of 
production of cloned  gene  products. 
T h e  ArsR protein is an example of a membrane protein 
that cannot be increased in amount through transcriptional 
control.  Even  though  the ars operon is a single  transcriptional 
unit,  the ArsA and ArsC proteins  were  produced in proportion 
to the  number of plasmid  copies of the  operon,  whereas  the 
ArsR protein was not ( 2 ) .  T h e  nrsH gene was cloned into 
vectors using a variety of promoters, including tandem Xpl. 
and  Xpf, promoters (Is), the  T7 RNA polymerase promoter 
(38), pInC (39), and P , ~ , ~  (40).  All were  ineffective in increasing 
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the level of arsenite resistance. The ArsB protein could only 
be detected as a labeled band on SDS-polyacrylamide gels 
when expressed as  an [35S]methionine-labeled protein under 
the T7 promoter  (27). 
Other possible reasons for the poor expression of the wild- 
type arsB gene could be due to 1) inefficient codon usage, 2) 
poor translational initiation, 3) instability of mRNA, and/or 
4) instability of the ArsB  protein. Previous studies  had shown 
that  the mRNA transcript was not stable, with degradation 
occurring within the arsB reading frame. The  other reading 
frames were  more stable, so that  the ArsA and ArsC proteins 
continued to be made even after  the  full-len~h message was 
broken down. Analysis of the arsB TIR revealed several 
details. First, the second codon, UUA, is not  the most fre- 
quently utilized leucine codon (9). Second, a GC-rich palin- 
dromic sequence of 8 base pairs between the  third  and twelfth 
codons could potentially form a  stable (-17 kcal/mol) stem- 
loop structure (8). Third,  the mRNA immediately before the 
initiating AUG codon of the arsB reading frame is UUU, 
which has been shown to have a  drastically negative effect on 
translational initiation of the lac2 message (41). Expression 
of eukaryotic membrane  protein in E. coli has also been linked 
to  efficient translation (42). Thus,  the  rate of ArsB protein 
synthesis could be limited by the rate at which ribosomes 
moved past  the  start of the reading frame. The mRNA past 
the bottleneck would be relatively unpopulated by ribosomes 
and  thus susceptible to endonuclease digestion. Two exori- 
bonucleases, polynucleotide phosphorylase (pnp)  and  RNase 
11 ( a m ) ,  have been shown to be involved in mRNA degrada- 
tion (43). There was no increase in arsenite  resistance when 
the ars operon was expressed in E. coli strain SK5671 carrying 
mutations in  both the urns and pnp genes: so that mRNA 
degradation alone may not be responsible for the observed 
differential translation. It could, however, result from the 
combination of these factors. These speculations were the 
basis for the modifications of the arsB gene, where the second 
codon was changed to the more frequently utilized leucine 
codon CUG and  the stem-loop structure was destabilized. A 
restriction site was created at  the beginning of the arsB gene 
to allow cloning into a vector with the highly expressed atpE 
TIR (15). The results of these  manipulations were unstable 
plasmids and no increase in production of the ArsB  protein. 
For whatever reasons, the desired outcome was not achieved 
by  this approach. 
A more fruitful  result was obtained by fusing the re-engi- 
neered arsB gene with a large portion of the arsA gene. This 
was not simply accidental. The arsA gene is highly expressed, 
with a TIR very similar to  that of lac2 (41). The chimeric 
ArsAB2 protein could be expressed at  levels comparable to 
that of the ArsA protein, which is 100-fold greater than  that 
of the wild-type ArsB protein. The chimeric protein is func- 
tional in  resistance and  transport,  but  the  amount of func- 
tional protein required to produce a  resistance  phenotype is 
not known. Isolated membranes with the chimeric protein 
bound only 5-&fold more purified ArsA protein than did 
membranes with the wild-type ArsB protein, suggesting that 
not all of the chimeric protein may  be active. In conclusion, 
these results  establish that  the difficulty in expressing genes 
for membrane  proteins in E, coli can be related in some cases 
to  translational initiation. However, even when the cause is 
recognized, the solution is not always obvious. M0dificat.ion.q 
of arsB that were anticipated to increase expression produced 
D. D o u   a n d  B. P. Rosen,  unpublished  results. 
lethality and plasmid instability. In fact, it is not clear why 
expression of the arsAB2 construct is not toxic to  the cell. 
The ability to make large amounts of the chimeric ArsAB2 
protein  demonstrates that conditions  can be found for pro- 
duction of even the most refractory membrane  proteins,  al- 
though  in this case the approach was more brute-force than 
systematic. 
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